APOP Pops On Study Data, EYEG Catches Investors' Eyes, CDTX Loses Radiance

Shares of Cellect Biotechnology Ltd. (APOP) rose over 15% on Tuesday, following positive final results from its clinical trial of ApoGraft in healthy donors.

from RTT - Biotech http://ift.tt/2lssuml
via IFTTT